NCT06225492View on ClinicalTrials.gov

DaxibotulinimtoxinA for Treatment of Platysmal Neck Bands

PHASE4CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

January 1, 2024

Primary Completion Date

January 1, 2025

Study Completion Date

January 1, 2025

Conditions
Aging
Interventions
DRUG

DaxibotulinumtoxinA 15 units

Subjects will be treated with 15 units of daxibotulinumtoxinA per platysmal band

DRUG

DaxibotulinumtoxinA 20 units

Subjects will be treated with 20 units of daxibotulinumtoxinA per platysmal band

Trial Locations (1)

19003

Main Line Center for Laser Surgery, Ardmore

All Listed Sponsors
lead

Main Line Center for Laser Surgery

OTHER

NCT06225492 - DaxibotulinimtoxinA for Treatment of Platysmal Neck Bands | Biotech Hunter | Biotech Hunter